Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
18.62
+0.85 (4.78%)
Nov 5, 2024, 4:00 PM EST - Market closed
Entrada Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | 54.95 | -6.69 | -94.62 | -51.16 | -26.52 | -5.1 |
Depreciation & Amortization | 3.52 | 2.84 | 1.9 | 1.12 | 0.33 | 0.1 |
Loss (Gain) From Sale of Assets | - | - | - | 0.07 | 0.02 | - |
Loss (Gain) From Sale of Investments | -9.51 | -5.78 | 0.15 | - | - | - |
Stock-Based Compensation | 17.06 | 13.11 | 9.9 | 2.53 | 0.33 | 0.29 |
Other Operating Activities | - | - | - | - | - | -6.27 |
Change in Accounts Receivable | 2.42 | -5.88 | - | - | - | - |
Change in Accounts Payable | 0.55 | -2.81 | 5.29 | -0.72 | 0.63 | 0.37 |
Change in Unearned Revenue | -105.06 | 139.98 | - | - | - | - |
Change in Income Taxes | 2.25 | 4.02 | - | - | - | - |
Change in Other Net Operating Assets | 19.86 | 1 | -16.4 | -2.71 | -0.35 | -0.19 |
Operating Cash Flow | -13.97 | 139.8 | -93.79 | -50.86 | -25.57 | -10.8 |
Capital Expenditures | -3.5 | -5.61 | -2.89 | -4.58 | -2.32 | -0.63 |
Investment in Securities | -58.62 | -132.78 | -145.76 | - | - | - |
Investing Cash Flow | -62.12 | -138.4 | -148.65 | -4.58 | -2.32 | -0.63 |
Issuance of Common Stock | 102.25 | 21.04 | 0.48 | 191.63 | 0.25 | 0.04 |
Financing Cash Flow | 102.25 | 21.04 | 0.48 | 307.46 | 50.09 | 0.04 |
Net Cash Flow | 26.17 | 22.45 | -241.96 | 252.02 | 22.2 | -11.39 |
Free Cash Flow | -17.46 | 134.19 | -96.67 | -55.44 | -27.89 | -11.43 |
Free Cash Flow Margin | -8.11% | 104.01% | - | - | - | - |
Free Cash Flow Per Share | -0.49 | 4.06 | -3.09 | -8.85 | -25.23 | -12.25 |
Cash Income Tax Paid | 14.72 | 14.72 | - | - | - | - |
Levered Free Cash Flow | -33.21 | 149.04 | -58.56 | -36.26 | -17.21 | - |
Unlevered Free Cash Flow | -33.21 | 149.04 | -58.56 | -36.26 | -17.21 | - |
Change in Net Working Capital | 82.45 | -140.68 | 6.68 | 3.37 | -1.13 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.